9-2717755-G-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_133497.4(KCNV2):āc.16G>Cā(p.Glu6Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,614,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_133497.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNV2 | NM_133497.4 | c.16G>C | p.Glu6Gln | missense_variant | 1/2 | ENST00000382082.4 | NP_598004.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNV2 | ENST00000382082.4 | c.16G>C | p.Glu6Gln | missense_variant | 1/2 | 1 | NM_133497.4 | ENSP00000371514 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251332Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135876
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461860Hom.: 0 Cov.: 67 AF XY: 0.0000138 AC XY: 10AN XY: 727236
GnomAD4 genome AF: 0.000361 AC: 55AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.000483 AC XY: 36AN XY: 74500
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2021 | The c.16G>C (p.E6Q) alteration is located in exon 1 (coding exon 1) of the KCNV2 gene. This alteration results from a G to C substitution at nucleotide position 16, causing the glutamic acid (E) at amino acid position 6 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Cone dystrophy with supernormal rod response Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 04, 2022 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 28, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at